Clinical Trial Update: Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 single-ascending-dose trial assessing safety, tolerability, and pharmacokinetics of MMV371 LAI in healthy participants; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• MMV371 LAI (MMV371 LAI)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria,Falciparum | Phase 1 | Status: COMPLETED